You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

11 Results
Guidelines and Advice
Status: Archived
ID: CED 20
Mar 2011
Guidelines and Advice
Status: Archived
ID: 1-20
Version: 2
Oct 2011
Guidelines and Advice
Status: Archived
ID: CED 23
Oct 2011
Guidelines and Advice
Status: Archived
ID: 1-12
Sep 2011
Guidelines and Advice
Status: Archived
ID: 2-18
Jun 2011
Guidelines and Advice
Status: Archived
ID: 2-22
Sep 2011
Guidelines and Advice
Status: Archived
ID: 21-3-3
Jan 2011
Guidelines and Advice
Status: Archived
ID: 8-4
Sep 2011
Guidelines and Advice
Status: Archived
ID: 1-15 Version 3
Version: 3
Sep 2011
Drug
Other Name(s): Mekinist®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2025
Regimen
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    trametinib - As monotherapy in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma, according to specific criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
trametinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2025